Performance analysis of Celldex Therapeutics (CLDX)
Annual Return
Over the past 3 years, CLDX has had an average annual return of -0.67%, underperforming the benchmark SPY, which returned +19.62% annual.
Over the past 5 years, CLDX has had an average annual return of -4.25%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, CLDX has had an average annual return of -6.67%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Nov 1, 1999, CLDX has had an average annual return of -8.28%, underperforming the benchmark SPY, which returned +8.49% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +31.43% | +7.41% | -36.30% | -10.99% | +15.38% | +120.33% | +685.48% | -24.39% | -93.07% | -19.80% | -77.42% | -14.08% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
| -24.62% | +260.80% | +158.17% | -36.92% | -11.77% | -41.03% | +32% | -62.69% | -28.72% | -6.47% | -26.64% | +142.48% |
| 2002 | 2001 | 2000 | 1999 | ||||||||
| -71.82% | -41.63% | +178.14% | +23.50% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -9.42% | +22.40% | +5.38% | +3.63% | -4.38% | +18.44% | -4.16% | +31.43% | |||||
| 2025 | -3.13% | -16.03% | -11.73% | +14.88% | -5.18% | +2.91% | +8.14% | +0.33% | +17.29% | +3.34% | +1.08% | +0.40% | +7.41% |
| 2024 | -11.25% | +36.50% | -12.66% | -10.89% | -10.97% | +11.14% | +3.02% | +8.40% | -17.77% | -23.31% | +5.25% | -7.87% | -36.30% |
| 2023 | -1.13% | -2.86% | -15.98% | -12.61% | +1.15% | +6.80% | +4.14% | -21.08% | -1.42% | -14.53% | +28.48% | +31.35% | -10.99% |
| 2022 | -19.76% | -3.48% | +13.84% | -10.25% | -23.09% | +14.70% | +13.89% | -1.06% | -7.46% | +24.97% | +5.53% | +20.19% | +15.38% |
| 2021 | +23.41% | +25.12% | -23.94% | +47.20% | -7.84% | +19.72% | +30.79% | +20.41% | +2.53% | -21.20% | -10.49% | +1.42% | +120.33% |
| 2020 | +3.23% | +14.06% | -36.99% | +47.83% | +8.82% | +387.84% | -20.78% | +16.08% | +24.10% | +6.80% | +42.05% | -22.08% | +685.48% |
| 2019 | +158.54% | -30.19% | -7.43% | -25.55% | -17.65% | -11.90% | -17.57% | -3.28% | +0% | +5.08% | +8.06% | -7.46% | -24.39% |
| 2018 | -2.79% | -18.43% | +3.52% | -68.28% | -21.43% | -13.22% | -7.62% | +7.73% | -10.05% | -30.32% | -5.34% | -33.87% | -93.07% |
| 2017 | -7.93% | +8.62% | +1.97% | -7.71% | -15.06% | -12.72% | -7.29% | +7.44% | +16.29% | -14.68% | +22.91% | -5.36% | -19.80% |
Drawdown analysis of Celldex Therapeutics (CLDX)
The maximum drawdown for the CLDX was -99.95%, occurring on Mar 20, 2020. This drawdown has not yet recovered.
The current CLDX drawdown is -98.82%.
Since Nov 1, 1999 CLDX has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 2 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.95% | Mar 6, 2000 | 5042 | Mar 20, 2020 | Ongoing | Ongoing | Ongoing |
| -28.28% | Nov 29, 1999 | 14 | Dec 17, 1999 | 9 | Dec 31, 1999 | 23 |
| -17.82% | Jan 26, 2000 | 4 | Feb 1, 2000 | 5 | Feb 8, 2000 | 9 |
| -17.35% | Nov 5, 1999 | 3 | Nov 10, 1999 | 11 | Nov 26, 1999 | 14 |
| -16.60% | Dec 31, 1999 | 2 | Jan 4, 2000 | 3 | Jan 7, 2000 | 5 |
| -10.86% | Feb 23, 2000 | 3 | Feb 28, 2000 | 2 | Mar 1, 2000 | 5 |
| -8.94% | Jan 13, 2000 | 1 | Jan 14, 2000 | 3 | Jan 20, 2000 | 4 |
| -5.66% | Nov 3, 1999 | 1 | Nov 4, 1999 | 1 | Nov 5, 1999 | 2 |
| -5.41% | Feb 11, 2000 | 2 | Feb 15, 2000 | 2 | Feb 17, 2000 | 4 |
| -4.02% | Feb 17, 2000 | 1 | Feb 18, 2000 | 1 | Feb 22, 2000 | 2 |
| -4.00% | Jan 24, 2000 | 1 | Jan 25, 2000 | 1 | Jan 26, 2000 | 2 |